Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,034.23 10.14 (0.99%) as of 4:30 Fri 7/5


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 108.27(B)
Last Volume: 418,302 Avg Vol: 758,271
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,995 237,237 312,646 469,880
Total Sell Value $189,656,342 $231,855,596 $295,997,978 $406,115,303
Total People Sold 7 13 16 18
Total Sell Transactions 18 40 67 129
End Date 2024-04-07 2024-01-05 2023-07-07 2022-07-07

   
Records found: 2433
  Page 73 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Terifay Robert J SVP Commercial   •       –      –    2012-01-10 4 D $73.92 $811,716 D/D (10,981) 18,391     -
   Terifay Robert J SVP Commercial   •       –      –    2012-01-10 4 OE $21.34 $427,886 D/D 20,000 19,488     -
   Goldstein Joseph L Director   –       •      –    2012-01-10 4 AS $74.35 $1,493,500 D/D (20,000) 10,000     -
   Goldstein Joseph L Director   –       •      –    2012-01-10 4 OE $19.69 $414,550 D/D 20,000 20,000     -
   Roberts William VP Regulatory Development and   •       –      –    2012-01-10 4 D $73.92 $2,093,710 D/D (28,324) 83,292     -
   Roberts William VP Regulatory Development and   •       –      –    2012-01-10 4 OE $20.32 $1,267,200 D/D 60,000 97,182     -
   Roberts William VP Regulatory Development and   •       –      –    2012-01-10 4 AS $74.35 $708,407 D/D (9,528) 61,144     -
   Yancopoulos George EVP, CSO & Pres, REGN Res Labs   •       •      –    2012-01-05 4 AS $58.00 $1,607,354 D/D (27,713) 833,041     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2011-12-20 4 OE $11.64 $29,100 D/D 2,500 89,361     -
   Schleifer Leonard S President & CEO   •       •      –    2011-12-16 4 D $52.03 $9,777,946 D/D (187,929) 156,063     -
   Schleifer Leonard S President & CEO   •       •      –    2011-12-16 4 OE $28.01 $7,002,500 D/D 250,000 343,992     -
   Yancopoulos George EVP CSO President Regeneron Re   •       •      –    2011-12-14 4 D $51.18 $1,971,249 D/D (38,516) 860,754     -
   Gilman Alfred G Director   –       •      –    2011-12-13 4 GD $0.00 $0 D/D 11,875 0     -
   Roberts William VP Regulatory Development and   •       –      –    2011-12-07 4 GD $0.00 $0 I/I 3,647 0     -
   Roberts William VP Regulatory Development and   •       –      –    2011-12-07 4 GD $0.00 $0 D/D 5,812 61,144     -
   Yancopoulos George EVP CSO President Regeneron Re   •       •      –    2011-12-01 4 AS $58.86 $1,645,591 D/D (27,713) 899,270     -
   Yancopoulos George EVP CSO President Regeneron Re   •       •      –    2011-11-30 4 D $58.19 $8,304,993 D/D (142,722) 926,983     -
   Yancopoulos George EVP CSO President Regeneron Re   •       •      –    2011-11-30 4 OE $28.01 $5,602,000 D/D 200,000 928,701     -
   Sing George L Director   –       •      –    2011-11-22 4 OE $28.81 $432,150 D/D 15,000 147,772     -
   Goldstein Joseph L Director   –       •      –    2011-10-14 4 AS $65.00 $650,000 D/D (10,000) 10,000     -
   Goldstein Joseph L Director   –       •      –    2011-10-14 4 OE $23.84 $238,400 D/D 10,000 20,000     -
   Terifay Robert J SVP Commercial   •       –      –    2011-10-11 4 AS $64.98 $471,218 D/D (7,214) 9,372     -
   Terifay Robert J SVP Commercial   •       –      –    2011-10-10 4 OE $21.34 $626,798 D/D 29,372 16,586     -
   Terifay Robert J SVP Commercial   •       –      –    2011-10-10 4 D $64.78 $828,277 D/D (12,786) 7,214     -
   Vagelos P Roy Chairman of the Board   •       •      –    2011-10-05 5 GD $0.00 $0 I/I 3,509 171,547     -
  2433 Records found
  Previous  70  71  72  73  74  75  76  77  78  79  Next   
  Page 73 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us